Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department

Abstract

ICB exposes patients to potentially severe IRAEs. Emergency physicians must identify patients treated with ICB and consider their toxicity when patients present to the ED with symptoms compatible with IRAEs.